LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)
$0.05274 -0.01226 (-18.8615%)
Analysed LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) News Sources
LGND: 1Q:26 Results Highlight Breadth of Portfolio
11-05-2026
yahoo.com
A Look At Ligand Pharmaceuticals (LGND) Valuation After Earnings Miss XOMA Deal And Viking TR-Beta Termination
12-05-2026
yahoo.com
Ligand (LGND) Q1 2026 Earnings Call Transcript
12-05-2026
fool.com
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
12-05-2026
yahoo.com
Ligand Pharmaceuticals' (NASDAQ:LGND) Strong Earnings Are Of Good Quality
15-05-2026
yahoo.com
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
16-05-2026
fool.com
Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?
19-05-2026
fool.com
Ligand to Participate in June Investor Conferences
27-05-2026
yahoo.com
OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake?
29-05-2026
fool.com
Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?
30-05-2026
fool.com
What is the current price of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The current price of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is $0.05274.
LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) since the previous trading day is $-0.01226.
LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) since the previous trading day is -18.8615%.
What is the most recent average sentiment score for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The most recent average sentiment score for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)?
The most recent sentiment for LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS) is .
SEC-8K** Filing Available For LIGAND PHARMA-GENERAL CVR (LGNYZ:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.